Sophie Evans’ Post

Sinaptica Therapeutics is a clinical-stage company that is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease. The company’s SinaptiStim System represents a totally new approach to treating AD by enhancing neuroplasticity via noninvasive neurostimulation of key brain networks involved in memory. The therapy has been clinically demonstrated to slow the progression of cognitive decline and functional decline in patients with mild-to-moderate Alzheimer's disease. Meet Sinaptica Therapeutics @ #Sachs_NIF More Info @ https://lnkd.in/eh5wh8Kj #NeuroscienceConference #CNS #CentralNervousSystem #BusinessDevelopment #Licensing #NeuroTech #Neuroscience #Neurosciences #Health #Investment #Healthcare #Brain #Alzheimers #Parkinsons #Neurology #Pain #BrainHealth #LifeSciences #Partnering #Innovation #InvestmentForum

Discover clarity on multiple sclerosis with our experts. schedule your sensitive MRI test today for a precise diagnosis. To book an appointment, contact: 04046999999 For more information, visit: virinchihospitals.com #MSAwareness #MRIExpertise #NeurologyCare #HealthCheckup #MSDiagnosis #MedicalExperts #NeuroScience #HealthcareNow #DiseaseDetection #HealthAwareness #MRIInsights #PrecisionMedicine #NeurologicalCare #MedicalTesting #WellnessJourney #HealthFirst #MSFighter #HealthScreening #Diagnostics #ExpertOpinion

🔍Ready to explore the frontiers of neurology?🌟 🧠 Join us at the Global Neurology Summit 2024! Dive deep into the world of Neurological Diseases with insights on Drugs, Diseases, Trials, and Patient Perspectives🌍 ➡️Learn more: https://bit.ly/4cf0vye 🌐Discover crucial topics like AI in Neurology, Epilepsy, Stroke, Parkinson's Disease, Headache Syndromes, Dementia, Multiple Sclerosis, and more🌟 💡Gain knowledge from leading industry experts and connect with a global community dedicated to advancing neurology👩⚕️ 🔔 Don't miss out to register at the earliest for this event✨ ➡️Follow #GNS2024 for more updates on Global Neurology Summit 2024! 🧠 #AI #NeurologySummit #MedicalConference #NeuroScience #NeurologicalDiseases #EpilepsyAwareness #StrokeResearch #ParkinsonsDisease #DementiaCare #MultipleSclerosis #eMedEvents #eMedEd

Exciting developments are on the horizon for Alzheimer's patients. A groundbreaking medication called Lecanemab has shown promise in significantly decelerating the advancement of this serious brain disorder. . . #VMC #VMCMedical #NewsOfTheWeek #AlzheimersResearch #Lecanemab #MedicalBreakthrough #BrainDisorderTreatment #HopeForAlzheimers #Neuroscience #MedicalInnovation #AlzheimersAwareness #AlzheimerPatients #HealthcareAdvancements #NeurologicalDisorders #BrainDisorder

Today is International Huntington’s Awareness Day, a day dedicated to raising awareness about the rare neurological disease which affects ~3 in 100,000 people worldwide. In this month’s edition of HRW Synapse’s Neuro News, Abigail Graham, Associate Director, has collated the recent advancements underway to improve the lives of people living with HD and help identify potential treatment options. Scroll through the carousel to find out more. If you’d like to find out more about HRW Synapse’s work in the Huntington’s space, please reach out to the team at [email protected] #huntingtonsdisease #huntingtonsawarenessday #huntingtonsawareness #internationalhuntingtonsawarenessday #neuroscience #synapse #carousel #neurologicaldisease #neurodisease #healthcare #healthcaremarketresearch #marketresearch #huntingtonstreatment #neurosciencenews #neuronews #carousel

🔍Ready to explore the frontiers of neurology?🌟 🧠 Join us at the Global Neurology Summit 2024! Dive deep into the world of Neurological Diseases with insights on Drugs, Diseases, Trials, and Patient Perspectives🌍 ➡️Learn more: https://bit.ly/3za1Vwa 🌐Discover crucial topics like AI in Neurology, Epilepsy, Stroke, Parkinson's Disease, Headache Syndromes, Dementia, Multiple Sclerosis, and more🌟 💡Gain knowledge from leading industry experts and connect with a global community dedicated to advancing neurology👩⚕️ 🔔 Don't miss out to register at the earliest for this event✨ ➡️Follow #GNS2024 for more updates on Global Neurology Summit 2024! 🧠 #GNS2024 #AI #NeurologySummit #MedicalConference #NeuroScience #NeurologicalDiseases #EpilepsyAwareness #StrokeResearch #ParkinsonsDisease #DementiaCare #MultipleSclerosis #eMedEvents #eMedEd

Have you ever heard of the homunculus? 🤩 The homunculus is an extraordinary part of the brain that maps the entire body of motor and somatosensory function within two cortical strips found in the frontal and parietal lobes. 💎 When we see deficits in motor and sensory function, we can determine where lesions are in the homunculus and provide a focused beginning point for our rehab techniques. 🧠 Lesions can come from strokes, brain damage through toxicology, traumatic brain injury and neurodegenerative diseases. The right rehab is so critical because we want to target neurogenesis and promote neuroplasticity with the most accurate stimulus in order to regain function.😲 Anyone else a neuro-nerd like me? 🤓🧠😍 . . . #brainhealth #neuroscience #speechpathology #neuroplasticity #cognitivehealth #braintraining #neurological #languagetherapy #brainscience #neurogenesis #mindhealth #aphasia #aphasiaawareness #neurorehab #neurorehabilitation #memoryboost #brainfitness #voicetherapy #neurologicaldisorder #healthymind #fluencybreakthrough #neuralplasticity #communicationdisorders #brainawareness #brainpower #growyourbrain

New Insights in #Stroke Treatment! The #ANGELREBOOT trial, a comprehensive study across 36 hospitals in #China, examined the effectiveness of adding #angioplasty or #stenting after #thrombectomy for #largevesselocclusion (#LVO) strokes. Conducted from December 2021 to March 2023, the trial included 348 patients. The results, published in The Lancet Neurology on June 21, 2024, showed no significant improvement in patient outcomes at 90 days and highlighted increased risks, including symptomatic #intracranialhemorrhage and #arterialdissection. Less is more! Despite the promising potential of these #bailoutprocedures, standard therapy remains the safer choice for now. Continued research and #clinicaltrials are essential to refining stroke treatment strategies. #Neurointervention #Neurovascular #Neurosurgery #Neuroradiology #Neurosurgeons #StrokeResearch #NeuroHealth #StrokeTreatment #Neuroscience #HealthcareInnovation #PatientSafety

PRIA Healthcare's Business Development Manager, Meghan DeChello, will be representing #PRIA at the American Academy of Neurology Annual Meeting from April 13th – 18th in #Denver! The #AAN24 Annual Conference is one of the largest gatherings of #neurologists and #neuroscience professionals, and we’re looking forward to connecting with innovators and pioneers in the space.    The American Academy of Neurology Annual Conference offers a prime platform to explore the latest advancements and cutting-edge research in neuroscience. With a robust history as a vital partner to over 250 medical device companies over 12 years, PRIA Healthcare understands the challenges facing #neuroscience innovators. From navigating complex #reimbursement pathways to accelerating speed to market strategies in a competitive landscape, #PRIA has been a crucial resource to countless innovators in #neurology.    Meghan will be on hand to discuss how #PRIA's tailored solutions can streamline these processes, mitigate common pain points in market access, and drive #commercialization success for new and novel #neurologicaltechnologies.    Don't miss this opportunity to connect with Meghan to explore how #PRIA can empower your technology’s journey in neuroscience. Reach out to Meghan today, to schedule a meeting at #AAN24! [email protected].   Click here to learn more about PRIA Healthcare:   https://lnkd.in/ebS3at_3   #AANAnnualMeeting #NeurologyInnovation #NeuroscienceResearch #MedTechInnovation #HealthcareInnovation #neuromodulation #neurostimulation Jeffrey Sirek, Stephanie DeFelice, eMBA, Marie A., Chelsy Peet

🧠 Unveiling MS Progression: Neurofilament Light Chain's Early Warning Signals📊 In a groundbreaking study published in JAMA Neurology, researchers have shed light on the intricate timeline of disability progression in multiple sclerosis (MS). The focus was on serum neurofilament light chain (NfL), a reliable marker of neuroaxonal injury. Key Findings: 1. Timing is Crucial: - NfL elevation detected approximately 1 year prior to disability worsening events associated with relapses. - Elevation observed 1-2 years before worsening events independent of clinical relapses. 2. Across MS Subtypes: - Replicated findings within the relapsing-remitting MS subgroup, emphasizing the universality of these neuroaxonal changes. Significance: Understanding the dynamics of NfL elevation provides critical insights into the poorly understood mechanisms contributing to disability accumulation in MS. Clinical Implications: - Potential for early intervention strategies targeting the identified window of dynamic central nervous system pathology. - Offers a glimpse into the intricacies of MS progression, guiding the development of more effective therapeutic approaches. Read the Full Study: Link in the comments #Neurology #MultipleSclerosis #MedicalResearch #ScienceUpdate #Neuroscience #HealthcareInnovation